Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Veronika Ferenc"'
Autor:
Barbara Peter, Karoline V. Gleixner, Sabine Cerny-Reiterer, Harald Herrmann, Viviane Winter, Emir Hadzijusufovic, Veronika Ferenc, Karina Schuch, Irina Mirkina, Hans-Peter Horny, Winfried F. Pickl, Leonhard Müllauer, Michael Willmann, Peter Valent
Publikováno v:
Haematologica, Vol 96, Iss 5 (2011)
Background In advanced systemic mastocytosis the response of neoplastic mast cells to conventional drugs is poor and the prognosis is bad. Current research is, therefore, attempting to identify novel drug targets in neoplastic mast cells. Polo-like k
Externí odkaz:
https://doaj.org/article/266949ddbdba4fd99fe7805468ab1d9b
Autor:
Peter Valent, Christian Sillaber, Winfried F. Pickl, Matthias Mayerhofer, Sabine Cerny-Reiterer, Emir Hadzijusufovic, Renata A. Meyer, Alexander Gruze, Barbara Peter, Veronika Ferenc, Karoline V. Gleixner
Supplementary Figure Legends 1-2 from Polo-like Kinase 1 (Plk1) as a Novel Drug Target in Chronic Myeloid Leukemia: Overriding Imatinib Resistance with the Plk1 Inhibitor BI 2536
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9204813a4bb4bc978aea1eed22bda2a1
https://doi.org/10.1158/0008-5472.22386731.v1
https://doi.org/10.1158/0008-5472.22386731.v1
Autor:
Peter Valent, Christian Sillaber, Winfried F. Pickl, Matthias Mayerhofer, Sabine Cerny-Reiterer, Emir Hadzijusufovic, Renata A. Meyer, Alexander Gruze, Barbara Peter, Veronika Ferenc, Karoline V. Gleixner
Supplementary Figures 1-2 from Polo-like Kinase 1 (Plk1) as a Novel Drug Target in Chronic Myeloid Leukemia: Overriding Imatinib Resistance with the Plk1 Inhibitor BI 2536
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f0fbc7b137b01d47f79d9b54190b379
https://doi.org/10.1158/0008-5472.22386728.v1
https://doi.org/10.1158/0008-5472.22386728.v1
Autor:
Peter Valent, Christian Sillaber, Winfried F. Pickl, Matthias Mayerhofer, Sabine Cerny-Reiterer, Emir Hadzijusufovic, Renata A. Meyer, Alexander Gruze, Barbara Peter, Veronika Ferenc, Karoline V. Gleixner
In most patients with chronic myeloid leukemia (CML), the disease can be kept under control using the BCR/ABL kinase inhibitor imatinib. Nevertheless, resistance or intolerance to imatinib and other BCR/ABL inhibitors may occur during therapy. Theref
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::064519f8922cd02485c8a465d23f2c3a
https://doi.org/10.1158/0008-5472.c.6501623.v1
https://doi.org/10.1158/0008-5472.c.6501623.v1
Autor:
Karoline V. Gleixner, Alexander Gruze, Renata A. Meyer, Peter Valent, Veronika Ferenc, Barbara Peter, Emir Hadzijusufovic, Winfried F. Pickl, Matthias Mayerhofer, Christian Sillaber, Sabine Cerny-Reiterer
Publikováno v:
Cancer Research. 70:1513-1523
In most patients with chronic myeloid leukemia (CML), the disease can be kept under control using the BCR/ABL kinase inhibitor imatinib. Nevertheless, resistance or intolerance to imatinib and other BCR/ABL inhibitors may occur during therapy. Theref
Autor:
Cem Akin, Veronika Ferenc, Charlotte van Iperen, Hanneke C. Kluin-Nelemans, Peter Valent, Willem G. Peters, Jaap J van Doormaal
Publikováno v:
Leukemia Research, 33(3), e19-22. PERGAMON-ELSEVIER SCIENCE LTD
Autor:
Keiryn L. Bennett, Winfried F. Pickl, Veronika Ferenc, Lily L. Remsing Rix, Christian Sillaber, Barbara Peter, Puchit Samorapoompichit, Harald Esterbauer, Christian Baumgartner, Alexander Gruze, Giulio Superti-Furga, Karoline V. Gleixner, Francis Y. Lee, Peter Valent
Publikováno v:
Experimental Hematology. 36:1244-1253
Objective Chronic eosinophilic leukemia (CEL) is a myeloproliferative disorder characterized by molecular and/or cytogenetic evidence of clonality of eosinophils, marked eosinophilia, and organ damage. In many patients, the transforming mutation FIP1
Autor:
P. Götzinger, Martin Ploder, M. Riedl, Raimund Jakesz, Peter Panhofer, Barbara Izay, Veronika Ferenc
Publikováno v:
European Surgery. 39:259-264
BACKGROUND: Tertiary peritonitis is defined as a severe recurrent or persistent intra-abdominal infection after adequate surgical source control. Aim of the study was to compare clinical outcome and microbial flora of patients with secondary and tert
Autor:
Winfried F. Pickl, Sabine Cerny-Reiterer, Michael Kneidinger, Matthias Mayerhofer, Christian Sillaber, Karl J. Aichberger, Alexander Gruze, Veronika Ferenc, Irina Mirkina, Peter Valent, Barbara Peter, Karoline V. Gleixner, Christian Baumgartner
Publikováno v:
Blood. 114(26)
Systemic mastocytosis (SM) is a myeloid neoplasm involving mast cells (MCs) and their progenitors. In most cases, neoplastic cells display the D816V-mutated variant of KIT. KIT D816V exhibits constitutive tyrosine kinase (TK) activity and has been im
Autor:
Hiroshi Maeda, Veronika Ferenc, Matthias Mayerhofer, Khaled Greish, Laura Rebuzzi, Rudin Kondo, Alexander Gruze, Puchit Samorapoompichit, Karoline V. Gleixner, Winfried F. Pickl, Maria Theresa Krauth, Arun K. Iyer, Michael Willmann, Michael Kneidinger, Peter Valent, Emir Hadzijusufovic, Barbara Peter
Publikováno v:
Experimental hematology. 36(11)
Objective Advanced mast cell (MC) neoplasms are usually resistant to conventional therapy. Therefore, current research focuses on new targets in neoplastic MC and development of respective targeted drugs. Mastocytomas in dogs often behave as aggressi